Said Dermime

Hamad Medical Corporation, Qatar


Said Dermime graduated with a B.S. degree in biological sciences from the University of Constantine, Constantine, Algeria, in 1985. He then received his M.S. and Ph.D. degrees in immunology from Salford University, Manchester, UK, in 1987 and 1992, respectively. Recently, Dermime was recruited by the NCCCR, Hamad Medical Corporation, Doha, Qatar, to establish and lead the Translational Cancer Research Facility. Yet, Dermime joined the National Cancer Institute, Milan, Italy, for a period of 2 years as a Postdoctoral Fellow, and the NHLBI, NIH, Bethesda, MD, USA, for another 2-year fellowship under an NIH Fogarty International Award. To gain industrial experience, Dermime worked at PPL Therapeutics Limited, London, UK, and COBRA Therapeutics Ltd., UK, for a period of 2 years. In addition, Dermime was appointed in 1998 at the PICR, Manchester, UK, as a Lymphoma-Cancer-Vaccine Team Leader for 4 years. Subsequently, Dermime established and led the Tumor Immunology Section, KFSHRC, Riyadh, Saudi Arabia, for a period of 6 years as a Senior Scientist. Later, Dermime joined the Dasman Diabetes Institute, Kuwait City, Kuwait, in 2008, to establish and lead the Department of Biomedical Research and to head the Immunology and Innovative Cell Therapy Unit. In 2012, he joined King Fahad Specialist Hospital, Dammam, Saudi Arabia, to establish the Biomedical Research Facility and to head the Immunology and Innovative Cell Therapy Program. Dermime is a member of several international scientific societies, an active member of the editorial board of some immunology journals, and a member of scientific boards of some international organizations. He supervised several Ph.D. and M.S. degrees students and received several research grants from different organizations such as Christie Hospital Endowment Funds (UK), ASTF (UAE), KACST (KSA), and KFAS (Kuwait). Dermime also published over 42 peer-reviewed articles in high impact factor journals such as Blood, Cancer Research, Journal of Immunology, Clinical Cancer Research, Neoplasia, and Breast Cancer Research.

Biography Updated on 3 November 2016

Scholarly Contributions [Data Provided by ]